MACo Supports Upper Payment Limits to Secure Prescription Drug Affordability
On February 6, Associate Policy Director Karrington Anderson testified before the Health and Government Operations Committee in support of HB 424 - Prescription Drug Affordability Board - Authority for Upper Payment Limits (Lowering Prescription Drug Costs for All Marylanders Now Act). This bill enhances the authority of the Prescription Drug Affordability Board to establish a process for setting upper payment limits for prescription drug purchases and payor reimbursements in the state. This legislation strengthens efforts…